Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/0972-2327.165482 http://scihub22266oqcxt.onion/10.4103/0972-2327.165482 C4683892!4683892!26713025     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Indian+Acad+Neurol 2015 ; 18 (4): 459-63 Nephropedia Template TP {{tp|p=26713025|t=2015. Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis |pdf=|usr=}}{{26713025}} gab.com Text Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis JO: Ann Indian Acad Neurol http://www.kidney.de/pget.php?&tw=1&pmid=26713025 #FOAvip Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell transplantation seems to be promising in recent literature. The current case report is a novel evidence for autologous hematopoietic stem cell transplantation (HSCT) in progressive MS. Case Summary: A 33 year old male with secondary progressive MS (SPMS), after being failed and/or intolerance to standard approved interferon (IFN) and mitoxantrone therapy, autologous HSCT was administered. At 2years of post-stem cell transplantation follow-up, he has remained stable with some improvement in functional status (Expanded Disability Status Scale (EDSS) reduced by 1.5), with no relapse, no treatment related complications, and no fresh magnetic resonance imaging (MRI) lesions. Conclusion: Autologous stem cell transplantation may be beneficial in progressive forms of MS, but needs to be tested in well-designed randomized trial. Twit Text FOAVip Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis ????Ann Indian Acad Neurol http://www.kidney.de/pget.php?&tw=1&pmid=26713025 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26713025 #FOAvip English Wikipedia <ref>{{Cite pmid|26713025}}</ref> Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis #MMPMID26713025 Pandit AK; Prasad K; Seth T Ann Indian Acad Neurol 2015[Oct]; 18 (4): 459-63 PMID26713025show ga Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell transplantation seems to be promising in recent literature. The current case report is a novel evidence for autologous hematopoietic stem cell transplantation (HSCT) in progressive MS. Case Summary: A 33 year old male with secondary progressive MS (SPMS), after being failed and/or intolerance to standard approved interferon (IFN) and mitoxantrone therapy, autologous HSCT was administered. At 2years of post-stem cell transplantation follow-up, he has remained stable with some improvement in functional status (Expanded Disability Status Scale (EDSS) reduced by 1.5), with no relapse, no treatment related complications, and no fresh magnetic resonance imaging (MRI) lesions. Conclusion: Autologous stem cell transplantation may be beneficial in progressive forms of MS, but needs to be tested in well-designed randomized trial. äAutologous hematopoietic stem cell transplantation in progressive seve(epmc).pdf DeepDyve Pubget Overpricing